Targeted vaccine allocation could increase the covid-19 vaccine benefits amidst its lack of availability: A mathematical modeling study in indonesia

With a limited number of vaccines and healthcare capacity shortages, particularly in low-and middle-income countries, vaccination programs should seek the most efficient strategy to reduce the negative impact of the COVID-19 pandemics. This study aims at assessing several scenarios of delivering the vaccine to people in Indonesia. We develop a model for several scenarios of delivering vaccines: without vaccination, fair distribution, and targeted distribution to five and eight districts with the highest COVID-19 incidence in West Java, one of the most COVID-19-affected regions in Indonesia. We calculate the needs of vaccines and healthcare staff for the program, then simulate the model for the initial 4-month and one-year scenarios. A one-year vaccination program would require 232,000 inoculations per day by 4833 vaccinators. Targeted vaccine allocation based on the burden of COVID-19 cases could benefit the COVID-19 vaccination program by lowering at least 5000 active cases. The benefits would increase by improving the number of vaccines and healthcare staff. Amidst lacking available vaccines, targeted vaccine allocation based on the burden of COVID-19 cases could increase the benefit of the COVID-19 vaccination program but still requires progressive efforts to improve healthcare capacity and vaccine availability for optimal protection for people.


See full article here: https://www.mdpi.com/2076-393X/9/5/462

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Call for more investment in cost-effective tuberculosis care
18 Juni 2021
The global community is facing a considerable challenge to eliminate tuberculosis (TB). Although the...
Good Knowledge but Poor Practice Toward COVID-19 Among Indonesian Youth
18 Juni 2021
COVID-19 cases have been increasing among young people as they are often considered to have low compliance...
COVID-19 and tuberculosis-related catastrophic costs
28 Maret 2021
The COVID-19 pandemic has created an unprecedented health crisis and a substantial socioeconomic impact....
Cost of seeking care for tuberculosis since the implementation of universal health coverage in Indonesia
28 Maret 2021
Background Although tuberculosis (TB) patients often incur high costs to access TB-related services,...
Catastrophic costs due to tuberculosis worsen treatment outcomes: a prospective cohort study in Indonesia
28 Maret 2021
Background While the incidence of catastrophic costs due to tuberculosis (TB) remains high, there...
Prognostic factors for TB-associated uveitis in the Asia-Pacific Region: results of a modified Delphi survey
28 Maret 2021
Background Prognostic factors for TB-associated uveitis (TBU) remain mostly unknown, due to the challenges...
Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios
28 Maret 2021
Background The World Health Organization’s End Tuberculosis Strategy states that no tuberculosis (TB)-affected...
A health economic evaluation of using N-terminal pro brain natriuretic peptide for the management of acute heart failure: A pilot study in an Indonesian tertiary referral hospital
28 Maret 2021
Heart failure represents a major health problem and economic burden also in development countries such...
Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage
28 Maret 2021
Background As well as imposing an economic burden on affected households, the high costs related to...
Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households
28 Maret 2021
BACKGROUND:Indonesia is the second-highest country for tuberculosis (TB) incidence worldwide. Hence,...